tiletamine hydrochloride has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aryandono, T; Chao, TY; Deng, L; Fong, IH; Haryana, SM; Huang, CC; Huang, WC; Lin, CC; Liu, HW; Ong, JR; Satriyo, PB; Su, CM; Tzeng, YM; Yeh, CT | 1 |
| D'Alessandro, N; Labbozzetta, M; Notarbartolo, M; Poma, P | 1 |
2 other study(ies) available for tiletamine hydrochloride and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclohexanones; DNA Damage; DNA Repair; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers.
Topics: Benzamides; Cell Line, Tumor; Curcumin; Cyclohexanones; Female; Humans; NF-kappa B; Precision Medicine; Signal Transduction; Triple Negative Breast Neoplasms | 2017 |